Abstract
Reactive oxygen species (ROS) and nitric oxide (NO) are important participants in signal transduction that could provide the cellular basis for activity-dependent regulation of neuronal excitability. In young rat cortical brain slices and undifferentiated PC12 cells, paired application of depolarization/agonist stimulation and oxidation induces long-lasting potentiation of subsequent Ca2+ signaling that is reversed by hypoxia. This potentiation critically depends on NO production and involves cellular ROS utilization. The ability to develop the Ca2+ signal potentiation is regulated by the developmental stage of nerve tissue, decreasing markedly in adult rat cortical neurons and differentiated PC12 cells.
Reactive oxygen/nitrogen species (ROS/RNS) often are considered as tissue-damaging agents in connection with oxidative stress, aging, and neurodegenerative diseases (1), especially in the presence of elevated cytosolic Ca2+ (2). For instance, during reperfusion injury, excess oxidants may induce Ca2+ excitoxicity (3). However, oxidants such as superoxide anion (O2⨪), peroxynitrite (ONOO−), and hydrogen peroxide (H2O2) are synthesized by the cell during its normal activity (4). Moreover, brain-imaging techniques (5) demonstrate that functionally active neurons show increased metabolic activity and oxygen consumption, resulting in higher levels of ROS/RNS. For example, visual stimulation causes the consumption of glucose and oxygen to rise in the human visual cortex (6, 7). This interdependence between the neuronal metabolic state and functional activity indicates a possible physiological role for ROS/RNS as potential regulators of neuronal activity. The idea of possible involvement of ROS and free radicals in electrical and developmental neuronal plasticity has been suggested recently (2, 8); however, no direct evidence at the cellular level has been presented.
Like other posttranslational modifications, such as phosphorylation, oxidation of amino acid residues in proteins promoted by ROS/RNS alters properties of a number of cellular proteins involved in neuronal excitability and Ca2+ signaling, from voltage-gated K+ and Ca2+ channels to ryanodine receptor and calmodulin (9–14). Modulation of cytosolic Ca2+-signaling pathways in neurons by ROS therefore could induce dramatic and long-term changes in the cellular excitability and neuronal activity. For example, increased cytosolic Ca2+ concentrations ([Ca2+]c) often lead to activation of Ca2+-dependent gene expression of regulatory factors such as the cAMP response element (CRE) and the CREB-binding protein, which often are considered to play roles in long-term information storage (15). The free radical and the second messenger nitric oxide (NO) also exerts its long-term effects on plasticity and development of nerve tissue interacting with Ca2+ signaling (16, 17). An extremely prolonged increase in [Ca2+]c, however, may lead to neuronal cell death (18), particularly during ischemia/reperfusion and oxidative stress (19). Therefore, oxidation promoted by ROS and free radicals potentially could alter the elements involved in Ca2+ homeostasis and long-term excitability to influence neuronal information storage at the single-cell, synaptic, and higher levels. In this report, we demonstrate that temporal pairing of depolarization/chemical stimulation and oxidation promoted by ROS potentiates cytosolic Ca2+ signaling in an activity- and NO-dependent manner and that this intracellular Ca2+ signal plasticity is developmentally regulated.
Materials and Methods
PC12 cells (CLONTECH) were grown in DMEM containing 85% horse serum, 10% FBS, 5% 2 mM l-glutamine, 100 mg/ml G418, 100 units/ml penicillin G, and 100 mg/ml streptomycin, at 10% CO2, on poly-l-lysine-covered glass coverslips. Cells were loaded with 1 μM fura-2 AM (Molecular Probes) for 1 h, washed, and mounted in the chamber of the spectrofluorimeter (F-4500; Hitachi, Tokyo). The standard recording medium contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 5 mM glucose, and 10 mM Hepes, pH 7.4 (NaOH). High-K+ medium contained an additional 30 mM KCl in place of NaCl. The chamber was constantly perfused with the recording medium. Measurements of [Ca2+]c were performed essentially as described (20). To induce oxidation by O2, the recording solution was bubbled with 100% O2 for 10 min immediately before application. Application of H2O2 and O2 at the concentrations used in this study had no significant effects on the fura-2 isobestic signal at 360 nm and did not alter the fura-2 responses to Ca2+. For NO measurements, PC12 cells were incubated for 1 h at room temperature with 10 μM DAF-2 DA (Calbiochem) in the standard recording medium and washed, and NO levels were measured essentially as described by Kojima et al. (21). Basal level of NO production was measured before stimulation and subtracted from the measurements. For ROS/RNS measurements, PC12 cells were incubated for 30 min in the medium containing 5 μM dihydrorhodamine 123 (Calbiochem) and washed, and ROS/RNS production was measured in the spectrofluorimeter (λex = 500 nm, λem = 530 nm). Basal level of ROS/RNS production was subtracted from the measurements.
Experiments with rats were carried out in accordance with the National Institutes of Health and the University of Iowa Animal Care and Use Guidelines. Rats (Long–Evans male; Harlan, Indianapolis) were decapitated, and the brain was removed rapidly and transferred to ice-cold saline containing 124 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 23 mM NaHCO3, and 10 mM glucose, pH 7.4 (95% O2/5% CO2). The coronal slices were prepared by cutting the rostral end of the neocortex on a Brinkmann chopper. Slices were loaded with 5 μM fura-2 AM for Ca2+ measurements. The medium was bubbled with 20% O2 for normoxia, 95% O2 for oxidation, and 0% O2 for hypoxia.
The amount of met(O) in the tissues was determined by treating the extracted protein with cyanogen bromide, which destroys methionine but not methionine sulfoxide (22, 23), and then subjecting the treated and nontreated samples to HCl hydrolysis as described (24). Under this condition, met(O) is quantitatively reduced to methionine and the amount of met in the cyanogen-treated sample divided by the met content in the untreated sample represents the fraction of met(O) in the extract.
All reagents were from Sigma unless otherwise stated. The experiments were carried out at room temperature (23°C).
Results
To address the role of ROS/RNS in intracellular Ca2+ signaling contributing to neuronal information storage, we examined how pairing of depolarization/chemical stimulation and oxidation alters subsequent intracellular Ca2+ signals induced by depolarization. The rat pheochromocytoma (PC12) neurosecretory cell line shows electrical excitability and developmental regulation by nerve growth factor (NGF) (25), and these cells were used as a model neuron system in this study. Repeated applications of high-K+-induced depolarization alone to either differentiated or undifferentiated PC12 cells elicited Ca2+ signals that are similar in amplitude, with no prolonged change in the basal [Ca2+]c (Fig. 1A). An application of 0.03% H2O2 evoked a small Ca2+ transient, but did not affect the subsequent Ca2+ responses to K+ depolarization (Fig. 1B). However, a single, combined application of depolarization and oxidation by H2O2 (0.03%) to undifferentiated PC12 cells markedly potentiated the subsequent Ca2+ signals in response to K+ depolarization (Figs. 1C and 2A). After this single, paired application of depolarization and oxidation, subsequent depolarization-induced Ca2+ signals developed faster and their amplitudes were dramatically greater (Fig. 2A). Typically, the Ca2+ signal was enhanced by 150–200% after the paired stimulation (Fig. 2 A and B, before and after). In addition, paired application of depolarization and oxidation induced a sustained elevation of the basal [Ca2+]c (Fig. 2A). This potentiation of cytosolic Ca2+ response in both the depolarization-induced signal and the basal level was maintained as long as the data collection continued, up to 2.5 h, indicating that a single pairing of depolarization and oxidation could have a very long-lasting impact on [Ca2+]c. Similar Ca2+ response potentiation also was obtained by paring depolarization and O2 (95%) instead of H2O2 (not shown).
The depolarization-induced [Ca2+]c signal potentiation induced by pairing of depolarization and oxidation was reversed by a brief hypoxia treatment (10 min) (Fig. 2A), providing an insight into physiological changes in neuronal cells induced by brain ischemic episodes. Interestingly, PC12 cells differentiated by NGF (100 ng/ml) did not show any sign of such potentiation, although a small decrease in the amplitude of the Ca2+ signal after hypoxia often was observed (Fig. 2 C and D). Moreover, the sustained elevation of [Ca2+]c observed after paired application of oxidation and depolarization in undifferentiated PC12 cells also was absent in the NGF-differentiated PC12 cells (Fig. 2C). Thus, potentiation of the [Ca2+]c signal induced by temporal pairing of oxidation and depolarization is regulated both by hypoxia and cellular differentiation.
The potentiation of the Ca2+ signal induced by paired application of depolarization and oxidation is likely to be a widespread phenomenon in excitable cells. The Ca2+ signals from rat cortical neurons demonstrated strikingly similar potentiation. Cells from young rats (9–30 days old) showed a long-lasting, sustained elevation of basal [Ca2+]c after a single, paired application of depolarization and oxidation with either H2O2 or O2 (Fig. 2E). A 2- to 3-fold increase in subsequent depolarization-induced Ca2+ signal was observed (compare the first and third responses to K+ depolarization, Fig. 2E). The neuronal rather than glial origin of this phenomenon was supported by the observation that incubation of the slices for 30 min with a glial-specific metabolic poison fluorocitrate (26) did not affect the Ca2+ signal potentiation by oxidation.
Similar to NGF-differentiated PC12 cells, the Ca2+ signal potentiation in the brain cells from young adult rats was much less pronounced, practically disappearing in the cells from the animals more than 40 days old (Fig. 2F). This observation suggests that the Ca2+ signal potentiation phenomenon may play roles in normal brain development. It is interesting to note that, in rat cortex development, the period between postnatal days 9 and 35 is considered to be the critical period for neuronal plasticity (27).
Oxidation potentiates the Ca2+ signaling when paired not only with depolarization but also, and even more dramatically, with chemical agonist stimulation. In PC12 cells, the neuromediator histamine evokes neurotransmitter release via activation of histamine receptors. In particular, activation of H2 receptors leading to stimulation of adenylyl cyclase activity and NO synthesis is implicated in regulation of cellular growth and differentiation (28). Histamine (100 μM) alone induced a very small Ca2+ signal in PC12 cells without affecting subsequent depolarization-induced Ca2+ signals (Fig. 3A), similar to application of H2O2 alone (Fig. 1B). However, when histamine and H2O2 were applied simultaneously, a long-lasting increase in [Ca2+]c was observed (Fig. 3B). Furthermore, after one-time paring of histamine application and oxidation, Ca2+ signals in response to depolarization were dramatically greater, typically by 200–300% (Fig. 3B), and this potentiation lasted up to 2 h. Similar potentiation was observed when histamine and O2 were applied concurrently (not shown). As found with pairing of depolarization and oxidation, the key requirement to induce the Ca2+ signal potentiation was the timing of pairing between chemical simulation of cells and oxidation. Only when these two stimuli were presented together was long-lasting enhancement of the Ca2+ signal observed.
H2O2 is a membrane-permeable oxidant, and, once in the intracellular compartment, it may react with oxidizable groups directly or react with biologically prevalent metal ions such as iron and copper (Fenton reaction) to form other strong oxidants such as the hydroxyl radical (4). We directly confirmed intracellular ROS/RNS production by using the fluorescent dye dihydrorhodamine (29) (Fig. 4). As expected, H2O2 application alone increased the level of ROS. Neither depolarization nor application of histamine alone induced any obvious change in the ROS level. However, when applied in combination with H2O2, these stimuli significantly reduced the increase in ROS caused by H2O2. Though seemingly unexpected, this result is in line with the possibility that ROS are consumed vigorously during depolarization/agonist stimulation to oxidize, directly or indirectly, the elements involved in cellular Ca2+ homeostasis. Consistent with this idea, in the presence of the reducing agent DTT (5 mM), paired application of depolarization and H2O2 did not increase the amplitude of subsequent responses to K+ depolarization (Fig. 5C).
Application of histamine to PC12 cells leads to enhanced NO synthesis (28). Thus, we examined whether NO may be involved in potentiation of Ca2+ signaling. Using the fluorescent dye DAF-2 (21), we measured NO production in PC12 cells during depolarization or histamine application. Application of 100 μM histamine induced a significant increase in NO production (Fig. 5A). During depolarization, however, the NO signal decreased, indicating that cellular NO consumption may have increased. We cannot totally exclude the possibility that the NO synthase activity decreased, although, considering the stimulation of NOS activity by Ca2+ and calmodulin (30), the [Ca2+]c rise during depolarization would be more likely to enhance the NOS activity. The important role of NO in oxidation-mediated Ca2+-signaling potentiation is demonstrated further in Fig. 5B, where we were able to mimic the potentiation induced by paired application of histamine and H2O2 by using the NO donor sodium nitroprusside (NaNP). Application of 100 μM NaNP on its own failed to elevate basal [Ca2+]c, and no subsequent potentiation of Ca2+ signaling was observed ([Ca2+]c rise during K+ depolarization amplitude: 1.4 ± 0.3, control, and 1.4 ± 0.4, after NaNP application). However, when H2O2 was applied concurrently, potentiation of subsequent Ca2+ responses as well as the sustained rise in [Ca2+]c were similar to the results obtained with histamine (Fig. 3B). Furthermore, in the presence of the NO scavenger hemoglobin (0.1 mM), paired application of histamine and oxidation did not potentiate the Ca2+ signal, and nitro-l-arginine methyl ester (l-NAME) (12 mM), the nitric oxide synthase (NOS) inhibitor, also abolished the Ca2+ signal potentiation (Fig. 5C). Taken together, these results suggest that pairing of depolarization/chemical stimulation and oxidation potentiates Ca2+ signaling in a NO-dependent manner. NO is often considered to react with O2⨪ to form the strong oxidant and nitrating agent peroxynitrite, which is implicated in ROS-mediated tissue injury (31). Direct application of peroxynitrite, however, did not cause any significant potentiation of the depolarization-Ca2+ signal (Fig. 5C). Stimulation of NO production and the presence of ROS/RNS therefore appear to be the key requirements for enhancement of the Ca2+ transient and the sustained elevation of [Ca2+]c, which, in turn, could trigger a number of pathways leading to plasticity of Ca2+ signaling in neuronal cells.
ROS/RNS readily promote oxidation of cysteine and methionine residues in proteins. Methionine is oxidized to methionine sulfoxide [met(O)], and its reduction is catalyzed by the enzyme peptide methionine sulfoxide reductase (MsrA; ref. 32). Depending on the activity level of MsrA, the effect of methionine oxidation could be short or long lasting. Methionine oxidation- reduction has been shown to alter the properties of voltage-gated K+ channels (11) and also implicated in up-regulation of voltage-gated Ca2+ channels (12). Thus, under oxidative conditions, the voltage-dependent pathway of Ca2+ entry into the excitable cell may be altered significantly. Furthermore, calmodulin, which plays critical roles in a large number of intracellular Ca2+-dependent processes including Ca2+ homeostasis, is regulated by methionine oxidation in an age-dependent way (33). Our results presented earlier show that the Ca2+ signal potentiation is preferentially observed in undifferentiated PC12 cells and in young neurons (see Fig. 2). This suggests that the MsrA activity and/or met(O) content of the tissue may be regulated developmentally in a similar fashion. Thus, we examined whether methionine oxidation is involved in the Ca2+ signal potentiation by measuring the tissue met(O) content and the MsrA enzymatic activity (22, 24). The changes in the MsrA activity and the relative met(O) concentration in the rat brain during the first 100 days are shown in Fig. 6. Both the MsrA activity and the met(O) concentration increased during the first 10 postnatal days, and then the MsrA activity level decreased markedly, whereas relative met(O) decreased only after day 30, which is thought to represent the end of the critical time for the cortex development (27). Undoubtedly, considering the complexity of the cellular Ca2+ homeostasis, multiple factors contribute to the observed oxidative Ca2+ signal potentiation and its regulation by development. The results presented suggest, however, that methionine oxidation and MsrA are likely to play an important role.
Discussion
We have demonstrated here that, in rat cortical neurons and a model PC12 cell line, one-time pairing of oxidation and depolarization/chemical stimulus dramatically enhances subsequent cellular Ca2+ signaling, representing a form of activity-dependent modulation of cellular excitability. The temporal pairing of depolarization and oxidation stimuli appears critical to potentiate the Ca2+ response, thus providing a physiological link between functional activity and the metabolic state of the neuronal cell through modulation of the Ca2+ homeostasis. Oxidation-mediated Ca2+ signal plasticity is observed preferentially in the developmentally young cells, disappearing after differentiation in culture and also after a specific brain development stage. Interestingly, hyperoxia has been shown to induce differentiated neuronal phenotype in PC12, possibly via production of ROS (34). This is consistent with our results that ROS/RNS are directly involved in activity-dependent neuronal differentiation.
The molecular mechanism of oxidative potentiation of Ca2+ signaling most likely involves a number of intracellular proteins involved in Ca2+ homeostasis. Oxidation of amino acid residues in ion channels is expected to alter cellular excitability and Ca2+ signaling (for review, see ref. 9). Oxidation of intracellular Ca2+ release channel ryanodine receptor and its resulting increased activity (13) may account for the sustained increase in basal [Ca2+]c observed during potentiation in our experiments (Fig. 2A). Calmodulin is also another prime target of oxidation. During development and aging, methionine residues in calmodulin undergo oxidation to met(O), resulting in the decreased ability of calmodulin to transduce Ca2+ signals (33). Oxidation of calmodulin would be expected to greatly contribute to the activity-dependent potentiation of Ca2+ signaling, as well as alter regulatory effects of calmodulin on ion channels, activation of plasma membrane Ca2+ pump, activation of NOS, and gene expression (35–38). Oxidative agents could have direct effects on gene transcription (39), and elevation of [Ca2+]c during potentiation also may function as a trigger for gene transcription via the CREB-binding protein CBP (40, 41), contributing to long-term cellular plasticity.
The crucial role for NO in oxidative potentiation of Ca2+ signaling triggered by pairing of electrical/agonist stimulation and oxidation demonstrated here provides an insight into the cellular mechanisms involved in neuronal developmental plasticity. NO could influence its effectors by stimulating the cGMP-dependent signaling pathway and/or by acting as a weak radical. This study does not directly address how these two mechanisms contribute to the Ca2+ potentiation. Acting as a radical, NO may directly affect the properties of voltage-dependent K+ channels and thus alter cellular excitability and Ca2+ signaling (42, 43). NO also has been implicated in cellular plasticity including neuronal differentiation and neurite outgrowth and, as recently suggested, in cortex development (44–46). In the rat cortex, NO synthesis has been shown to reach its maximum in the second postnatal week and start to decrease after day 20 (47, 48). Our findings that the Ca2+ potentiation depends on NO (Fig. 5) and becomes less pronounced with age (Fig. 2) and that increased MsrA activity and met(O) content are developmentally transient (see Fig. 6) suggest that oxidative Ca2+ potentiation may be closely linked with cortex development. It is also noteworthy that NO has been shown to amplify Ca2+-induced gene transcription and trigger growth arrest during differentiation of PC12 cells when NO application coincided with Ca2+ influx (16, 49), which closely resembles our experimental paradigm reported here.
Activity-, NO-, and ROS-dependent potentiation of Ca2+ signaling and the resulting increased neuronal excitability could provide a basis for information storage at the cellular level. The observation that this oxidative Ca2+ potentiation can be reversed by brief hypoxia (Fig. 2A) might provide an insight into understanding the damaging effects of oxygen deprivation on brain function. This study presents the phenomenon of oxidative potentiation of neuronal excitability and Ca2+ signaling and establishes its connection with neuronal differentiation through neuronal development factors such as NO, Ca2+, and NGF, as well as the redox activity of the tissue (MsrA expression). We suggest that the above potentiation of Ca2+ signaling may contribute to a long-lasting increase in neurotransmitter release by active neurons and, thus, may be involved in synaptic modulation and higher brain functions.
Acknowledgments
This paper is dedicated to the late L. Fulson. We thank Dr. J. Thommandru for PC12 cell cultures. This work was supported in part by National Institutes of Health Grants GM57654, HL14388, and DFG He2993/1.
Abbreviations
- ROS
reactive oxygen species
- RNS
reactive nitrogen species
- NGF
nerve growth factor
- NOS
nitric oxide synthase
- MsrA
methionine sulfoxide reductase
- NaNP
sodium nitroprusside
References
- 1.Beckman K B, Ames B N. Physiol Rev. 1998;78:547–581. doi: 10.1152/physrev.1998.78.2.547. [DOI] [PubMed] [Google Scholar]
- 2.Mattson M P. Perspect Dev Neurobiol. 1996;3:79–91. [PubMed] [Google Scholar]
- 3.Giroux C, Scatton B. Eur Neurol. 1996;36:61–64. doi: 10.1159/000117208. [DOI] [PubMed] [Google Scholar]
- 4.Acworth I N, McCabe D A, Maher T J. In: Antioxidants, Oxidants and Free Radicals. Baskin S, Salem H, editors. London: Taylor and Francis; 1997. pp. 23–25. [Google Scholar]
- 5.Davis T L, Kwong K K, Weisskoff R M, Rosen B R. Proc Natl Acad Sci USA. 1998;95:1834–1839. doi: 10.1073/pnas.95.4.1834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chen W, Novotny E J, Zhu X H, Rothman D L, Shulman R G. Proc Natl Acad Sci USA. 1993;90:9896–9900. doi: 10.1073/pnas.90.21.9896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vafaee M S, Marrett S, Meyer E, Evans A C, Gjedde A. Acta Neurol Scand. 1998;98:85–89. doi: 10.1111/j.1600-0404.1998.tb01724.x. [DOI] [PubMed] [Google Scholar]
- 8.Auerbach J M, Segal M. J Neurosci. 1997;17:8695–8701. doi: 10.1523/JNEUROSCI.17-22-08695.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kourie J I. Am J Physiol. 1998;275:C1–C24. doi: 10.1152/ajpcell.1998.275.1.C1. [DOI] [PubMed] [Google Scholar]
- 10.Ruppersberg J P, Stocker M, Pongs O, Heinemann S H, Frank R, Koenen M. Nature (London) 1991;352:711–714. doi: 10.1038/352711a0. [DOI] [PubMed] [Google Scholar]
- 11.Ciorba M A, Heinemann S H, Weissbach H, Brot N, Hoshi T. Proc Natl Acad Sci USA. 1997;94:9932–9937. doi: 10.1073/pnas.94.18.9932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Li A, Segui J, Heinemann S H, Hoshi T. J Neurosci. 1998;18:6740–6747. doi: 10.1523/JNEUROSCI.18-17-06740.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Xu L, Eu J P, Meissner G, Stamler J S. Science. 1998;279:234–237. doi: 10.1126/science.279.5348.234. [DOI] [PubMed] [Google Scholar]
- 14.Gao J, Yin D H, Yao Y, Sun H, Qin Z, Schoneich C, Williams T D, Squier T C. Biophys J. 1998;74:1115–1134. doi: 10.1016/S0006-3495(98)77830-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Silva A J, Kogan J H, Frankland P W, Kida S. Annu Rev Neurosci. 1998;21:127–148. doi: 10.1146/annurev.neuro.21.1.127. [DOI] [PubMed] [Google Scholar]
- 16.Peunova N, Enikolopov G. Nature (London) 1993;364:450–453. doi: 10.1038/364450a0. [DOI] [PubMed] [Google Scholar]
- 17.Lev-Ram V, Jiang T, Wood J, Lawrence D S, Tsien R Y. Neuron. 1997;18:1025–1038. doi: 10.1016/s0896-6273(00)80340-2. [DOI] [PubMed] [Google Scholar]
- 18.McGinnis K M, Wang K K, Gnegy M E. J Neurochem. 1999;72:1853–1863. doi: 10.1046/j.1471-4159.1999.0721853.x. [DOI] [PubMed] [Google Scholar]
- 19.Chakraborti T, Das S, Mondal M, Roychoudhury S, Chakraborti S. Cell Signal. 1999;11:77–85. doi: 10.1016/s0898-6568(98)00025-4. [DOI] [PubMed] [Google Scholar]
- 20.Grynkiewicz G, Poenie M, Tsien R Y. J Biol Chem. 1985;260:3440–3450. [PubMed] [Google Scholar]
- 21.Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Anal Chem. 1998;70:2446–2453. doi: 10.1021/ac9801723. [DOI] [PubMed] [Google Scholar]
- 22.Villa S, De Faszio G, Canosi U. Anal Biochem. 1989;177:161–164. doi: 10.1016/0003-2697(89)90032-8. [DOI] [PubMed] [Google Scholar]
- 23.Joppich-Kuhn R, Corkill J A, Giese R W. Anal Biochem. 1982;119:73–77. doi: 10.1016/0003-2697(82)90666-2. [DOI] [PubMed] [Google Scholar]
- 24.Brot N, Werth J, Koster D, Weissbach H. Anal Biochem. 1982;122:291–294. doi: 10.1016/0003-2697(82)90283-4. [DOI] [PubMed] [Google Scholar]
- 25.Obermeier A, Bradshaw R A, Seedorf K, Choidas A, Schlessinger J, Ulrich A. Ann N Y Acad Sci. 1995;766:1–17. doi: 10.1111/j.1749-6632.1995.tb26643.x. [DOI] [PubMed] [Google Scholar]
- 26.Fonnum F, Johnsen A, Hassel B. Glia. 1997;21:106–113. [PubMed] [Google Scholar]
- 27.Fox K. Neuron. 1995;15:485–488. doi: 10.1016/0896-6273(95)90136-1. [DOI] [PubMed] [Google Scholar]
- 28.Del Valle J, Gantz I. Am J Physiol. 1997;273:G987–G996. doi: 10.1152/ajpgi.1997.273.5.G987. [DOI] [PubMed] [Google Scholar]
- 29.Crow J P. Nitric Oxide. 1997;1:145–157. doi: 10.1006/niox.1996.0113. [DOI] [PubMed] [Google Scholar]
- 30.Bredt D S, Snyder S H. Proc Natl Acad Sci USA. 1990;87:682–685. doi: 10.1073/pnas.87.2.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Stadtman E R, Berlett B S. Drug Metab Rev. 1998;30:225–243. doi: 10.3109/03602539808996310. [DOI] [PubMed] [Google Scholar]
- 32.Moskovitz J, Weissbach H, Brot N. Proc Natl Acad Sci USA. 1996;93:2095–2099. doi: 10.1073/pnas.93.5.2095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gao J, Yin D, Yao Y, Williams T D, Squier T C. Biochemistry. 1998;37:9536–9548. doi: 10.1021/bi9803877. [DOI] [PubMed] [Google Scholar]
- 34.Katoh S, Mitsui Y, Kitani K, Suzuki T. Biochem Biophys Res Commun. 1997;241:347–351. doi: 10.1006/bbrc.1997.7514. [DOI] [PubMed] [Google Scholar]
- 35.Zhang S, Ehlers M D, Bernhardt J P, Su C T, Huganir R L. Neuron. 1998;21:443–453. doi: 10.1016/s0896-6273(00)80553-x. [DOI] [PubMed] [Google Scholar]
- 36.Peterson B Z, DeMaria C D, Yue D T. Neuron. 1999;22:549–558. doi: 10.1016/s0896-6273(00)80709-6. [DOI] [PubMed] [Google Scholar]
- 37.Hellermann G R, Solomonson L P. J Biol Chem. 1997;272:12030–12034. doi: 10.1074/jbc.272.18.12030. [DOI] [PubMed] [Google Scholar]
- 38.Bito H, Deisseroth K, Tsien R W. Cell. 1996;87:1203–1214. doi: 10.1016/s0092-8674(00)81816-4. [DOI] [PubMed] [Google Scholar]
- 39.Zheng M, Storz G. Science. 1998;279:1718–1721. doi: 10.1126/science.279.5357.1718. [DOI] [PubMed] [Google Scholar]
- 40.Dolmetsch R E, Lewis R S, Goodnow C C, Healy J I. Nature (London) 1997;386:855–858. doi: 10.1038/386855a0. [DOI] [PubMed] [Google Scholar]
- 41.Hu S-C, Chirvia J, Ghosh A. Neuron. 1999;22:799–808. doi: 10.1016/s0896-6273(00)80738-2. [DOI] [PubMed] [Google Scholar]
- 42.Ciorba M A, Heinemann S H, Weissbach H, Brot N, Hoshi T. FEBS Lett. 1999;442:48–52. doi: 10.1016/s0014-5793(98)01616-0. [DOI] [PubMed] [Google Scholar]
- 43.Taglialatela, M., Pannaccione, A., Iossa, S., Castaldo, P. & Annunziato, L. (1999) Mol. Pharmacol.56, in press. [DOI] [PubMed]
- 44.Dawson T M, Sasaki M, Gonzalez-Zulueta M, Dawson V L. Prog Brain Res. 1998;118:3–11. doi: 10.1016/s0079-6123(08)63196-9. [DOI] [PubMed] [Google Scholar]
- 45.Hindley S, Juurlink B H, Gysbers J W, Middlemiss P J, Herman M A, Rathbone M P. J Neurosci Res. 1997;47:427–439. [PubMed] [Google Scholar]
- 46.Cramer K S, Leamey C A, Sur M. In: Progress in Brain Research. Mize R R, Dawson T M, Friedlander M J, editors. Amsterdam: Elsevier Science; 1998. pp. 101–114. [Google Scholar]
- 47.Luth H J, Hedlich A, Hilbig H, Winkelmann E, Mayer B. J Hirnforschung. 1995;36:313–328. [PubMed] [Google Scholar]
- 48.Bravo H, Inzunza O, Fernandez V, Sanhueza M. Neurosci Lett. 1997;234:103–106. doi: 10.1016/s0304-3940(97)00689-7. [DOI] [PubMed] [Google Scholar]
- 49.Peunova N, Enikolopov G. Nature (London) 1995;375:68–73. doi: 10.1038/375068a0. [DOI] [PubMed] [Google Scholar]